$BBOT 3 SEC Filings

Filed On	Filing
30 Apr 2026	Form 3: Cobo Marc, Principal Accounting Officer Holds 5,431 shares of Common Stock
30 Apr 2026	Form 3: Elmelech Idan, COO & Principal Financial Ofcr Holds 14,838 shares of Common Stock
26 Mar 2026	Form 3: Lebowitz Peter F, Director No securities owned
18 Aug 2025	Form 3: Tipirneni Praveen P., Director
18 Aug 2025	Form 3: Doig Michelle, Director No securities owned
18 Aug 2025	Form 3: Mccormick Frank, Director
18 Aug 2025	Form 3: BridgeBio Pharma Llc, 10% owner and 1 other Holds 13,805,126 shares of Common Stock
18 Aug 2025	Form 3: Bauer Jake, Director No securities owned
18 Aug 2025	Form 3: Kumar Neil, Director No securities owned
18 Aug 2025	Form 3: Ben Yong, Chief Med & Dev Officer
18 Aug 2025	Form 3: Wallace Eli M., Director
18 Aug 2025	Form 3: Mehra Uneek, Chief Financial Officer No securities owned
18 Aug 2025	Form 3: Beltran Pedro, Chief Scientific Officer
11 Aug 2025	Form 3: Kelleher Raymond J., Director No securities owned
11 Feb 2025	Form 3: Holman Albert A Iii, Director
09 Feb 2024	Form 3: Schmid John P., Director
09 Feb 2024	Form 3: Tripp Caleb, Chief Financial Officer No securities owned
09 Feb 2024	Form 3: Chen Bihua, Director
08 Feb 2024	Form 3: Obradovic Nebojsa, Chief Legal Officer No securities owned
08 Feb 2024	Form 3: Helix Holdings Ii Llc, Director

Comments